Breaking News Instant updates and real-time market news.

ADCT

ADC Therapeutics

$35.30 /

+0.3 (+0.86%)

07:28
06/09/20
06/09
07:28
06/09/20
07:28

ADC Therapeutics initiated with a Buy at BofA

BofA analyst Tazeen Ahmad initiated coverage of ADC Therapeutics with a Buy rating and $45 price target. ADC has several programs already in late-stage development, including lead asset Lonca in Diffuse Large B-Cell Lymphoma, or DLBCL. A BLA for that drug is expected to be filed in September, with potential U.S. sales starting in 2021, noted Ahmad, who views the drug's existing efficacy data "as clinically significant" given the limited options available with balanced efficacy and tolerability. ADC is uniquely positioned in oncology with both manufacturing know-how and a portfolio of antibody drug conjugates that are highly differentiated, the analyst added.

ADCT ADC Therapeutics
$35.30 /

+0.3 (+0.86%)

06/09/20 BofA
ADC Therapeutics initiated with a Buy at BofA

TODAY'S FREE FLY STORIES

Upgrade
Satsuma Pharmaceuticals upgraded to Neutral from Underperform at Credit Suisse » 06:33
03/02/21
03/02
06:33
03/02/21
06:33
STSA

Satsuma Pharmaceuticals

/

+

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STSA Satsuma Pharmaceuticals
/

+

STSA Satsuma Pharmaceuticals
/

+

05:22 Today Credit Suisse
Satsuma upgraded to Neutral from Underperform at Credit Suisse
11/11/20 Mizuho
Satsuma Pharmaceuticals price target lowered to $3.50 from $4 at Mizuho
09/21/20 H.C. Wainwright
Satsuma Pharmaceuticals price target lowered to $7 from $35 at H.C. Wainwright
09/14/20 BTIG
Satsuma setback a positive for Zosano Pharma, says BTIG
STSA Satsuma Pharmaceuticals
/

+

Initiation
Bolt Biotherapeutics initiated with an Outperform at SVB Leerink » 06:33
03/02/21
03/02
06:33
03/02/21
06:33
BOLT

Bolt Biotherapeutics

/

+

SVB Leerink analyst Daina…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOLT Bolt Biotherapeutics
/

+

06:19 Today Guggenheim
Bolt Biotherapeutics initiated with a Buy at Guggenheim
  • 05
    Feb
BOLT Bolt Biotherapeutics
/

+

Initiation
Pharvaris initiated with an Outperform at SVB Leerink » 06:33
03/02/21
03/02
06:33
03/02/21
06:33
PHVS

Pharvaris

$40.08 /

+0.58 (+1.47%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHVS Pharvaris
$40.08 /

+0.58 (+1.47%)

PHVS Pharvaris
$40.08 /

+0.58 (+1.47%)

06:02 Today BofA
Pharvaris initiated with a Neutral at BofA
  • 05
    Feb
PHVS Pharvaris
$40.08 /

+0.58 (+1.47%)

Upgrade
Hims & Hers upgraded to Buy from Neutral at Citi » 06:33
03/02/21
03/02
06:33
03/02/21
06:33
HIMS

Hims & Hers

$15.26 /

+0.65 (+4.45%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

06:09 Today Citi
Hims & Hers upgraded to Buy from Neutral at Citi
02/17/21 Citi
Hims & Hers initiated with a Neutral at Citi
02/12/21
Fly Intel: Top five analyst initiations
02/12/21 Piper Sandler
Hims & Hers initiated with a Neutral at Piper Sandler
HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

HIMS Hims & Hers
$15.26 /

+0.65 (+4.45%)

Downgrade
Pembina Pipeline downgraded to Hold from Buy at Desjardins » 06:32
03/02/21
03/02
06:32
03/02/21
06:32
PBA

Pembina Pipeline

$26.06 /

+0.675 (+2.66%)

Desjardins analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBA Pembina Pipeline
$26.06 /

+0.675 (+2.66%)

PBA Pembina Pipeline
$26.06 /

+0.675 (+2.66%)

03/01/21 Industrial Alliance
Pembina Pipeline upgraded to Buy from Hold at Industrial Alliance
02/26/21 BMO Capital
Pembina Pipeline price target raised to C$37 from C$35 at BMO Capital
02/26/21 CIBC
Pembina Pipeline price target lowered to C$39 from C$40 at CIBC
02/09/21 Scotiabank
Pembina Pipeline downgraded to Sector Perform from Outperform at Scotiabank
PBA Pembina Pipeline
$26.06 /

+0.675 (+2.66%)

Earnings
Exterran reports Q4 adjusted EPS (74c), consensus (39c)  06:32
03/02/21
03/02
06:32
03/02/21
06:32
EXTN

Exterran

$5.50 /

+0.03 (+0.55%)

 
ShowHide Related Items >><<
EXTN Exterran
$5.50 /

+0.03 (+0.55%)

EXTN Exterran
$5.50 /

+0.03 (+0.55%)

09/08/20 Evercore ISI
Exterran upgraded to Outperform from In Line at Evercore ISI
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Northland
Exterran initiated with an Outperform at Northland
03/09/20 Evercore ISI
Exterran downgraded to In Line from Outperform at Evercore ISI
EXTN Exterran
$5.50 /

+0.03 (+0.55%)

Hot Stocks
Hertz files plan of reorganization, disclosure statement with bankruptcy court » 06:32
03/02/21
03/02
06:32
03/02/21
06:32
HTZGQ

Hertz

$1.79 /

+ (+0.00%)

Hertz announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HTZGQ Hertz
$1.79 /

+ (+0.00%)

HTZGQ Hertz
$1.79 /

+ (+0.00%)

HTZGQ Hertz
$1.79 /

+ (+0.00%)

Downgrade
Skyline Champion downgraded to Neutral from Outperform at Wedbush » 06:32
03/02/21
03/02
06:32
03/02/21
06:32
SKY

Skyline Champion

$46.76 /

+2.22 (+4.98%)

Wedbush analyst Jay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SKY Skyline Champion
$46.76 /

+2.22 (+4.98%)

SKY Skyline Champion
$46.76 /

+2.22 (+4.98%)

02/03/21 Craig-Hallum
Skyline Champion price target raised to $49 from $40 at Craig-Hallum
12/18/20 Barclays
Skyline price target raised to $36 from $32 at Barclays
12/18/20 Wedbush
Skyline initiated with an Outperform at Wedbush
12/17/20 Wedbush
Skyline initiated with an Outperform at Wedbush
SKY Skyline Champion
$46.76 /

+2.22 (+4.98%)

SKY Skyline Champion
$46.76 /

+2.22 (+4.98%)

Earnings
Exterran reports Q4 cont ops EPS ($1.03), consensus (39c) » 06:31
03/02/21
03/02
06:31
03/02/21
06:31
EXTN

Exterran

$5.50 /

+0.03 (+0.55%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXTN Exterran
$5.50 /

+0.03 (+0.55%)

EXTN Exterran
$5.50 /

+0.03 (+0.55%)

09/08/20 Evercore ISI
Exterran upgraded to Outperform from In Line at Evercore ISI
08/21/20
Fly Intel: Top five analyst initiations
08/21/20 Northland
Exterran initiated with an Outperform at Northland
03/09/20 Evercore ISI
Exterran downgraded to In Line from Outperform at Evercore ISI
EXTN Exterran
$5.50 /

+0.03 (+0.55%)

Recommendations
Acadia price target raised to $63 from $55 at RBC Capital » 06:30
03/02/21
03/02
06:30
03/02/21
06:30
ACAD

Acadia

$49.51 /

+0.51 (+1.04%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia
$49.51 /

+0.51 (+1.04%)

02/25/21 Mizuho
Acadia price target raised to $70 from $69 at Mizuho
12/29/20 Cantor Fitzgerald
Acadia price target raised to $70 from $61 at Cantor Fitzgerald
12/15/20 Mizuho
Acadia initiated with a Buy at Mizuho
11/16/20 Raymond James
Acadia upgraded to Strong Buy from Outperform at Raymond James
ACAD Acadia
$49.51 /

+0.51 (+1.04%)

Initiation
Clene initiated with a Buy at Benchmark » 06:29
03/02/21
03/02
06:29
03/02/21
06:29
CLNN

Clene

$13.47 /

+0.51 (+3.94%)

Benchmark analyst Bruce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLNN Clene
$13.47 /

+0.51 (+3.94%)

CLNN Clene
$13.47 /

+0.51 (+3.94%)

02/03/21 Roth Capital
Clene initiated with a Buy at Roth Capital
Recommendations
Dicerna price target raised to $40 from $35 at H.C. Wainwright » 06:28
03/02/21
03/02
06:28
03/02/21
06:28
DRNA

Dicerna

$28.88 /

+1.86 (+6.88%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

05:04 Today Chardan
Dicerna price target raised to $34 from $25 at Chardan
03/01/21 B. Riley Securities
Dicerna price target raised to $40 from $37 at B. Riley Securities
01/11/21 B. Riley Securities
Dicerna price target raised to $37 from $30 at B. Riley Securities
08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

DRNA Dicerna
$28.88 /

+1.86 (+6.88%)

Hot Stocks
Beacon Street Group to go public via merger with Ascendant Digital Acquisition » 06:27
03/02/21
03/02
06:27
03/02/21
06:27
ACND

Ascendant Digital Acquisition

$10.60 /

+0.01 (+0.09%)

Beacon Street Group, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACND Ascendant Digital Acquisition
$10.60 /

+0.01 (+0.09%)

Recommendations
Digital Media Solutions price target raised to $14 from $13 at Citi » 06:26
03/02/21
03/02
06:26
03/02/21
06:26
DMS

Digital Media Solutions

$10.70 /

-0.31 (-2.82%)

Citi analyst Nicholas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DMS Digital Media Solutions
$10.70 /

-0.31 (-2.82%)

DMS Digital Media Solutions
$10.70 /

-0.31 (-2.82%)

12/21/20 Craig-Hallum
Digital Media Solutions initiated with a Buy at Craig-Hallum
12/16/20 BTIG
Digital Media Solutions initiated with a Buy at BTIG
11/11/20 Citi
Digital Media Solutions price target raised to $13 from $12 at Citi
08/18/20 Citi
Digital Media Solutions initiated with a Buy at Citi
DMS Digital Media Solutions
$10.70 /

-0.31 (-2.82%)

Recommendations
Universal Health price target lowered to $151 from $162 at Citi » 06:26
03/02/21
03/02
06:26
03/02/21
06:26
UHS

Universal Health

$127.94 /

+2.08 (+1.65%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UHS Universal Health
$127.94 /

+2.08 (+1.65%)

UHS Universal Health
$127.94 /

+2.08 (+1.65%)

01/05/21 Deutsche Bank
Universal Health price target raised to $145 from $135 at Deutsche Bank
01/05/21 BofA
BofA sees tailwinds for healthcare facilities, names HCA Healthcare top pick
01/05/21 BofA
Universal Health downgraded to Underperform from Neutral at BofA
12/18/20 Mizuho
Universal Health price target raised to $151 from $130 at Mizuho
UHS Universal Health
$127.94 /

+2.08 (+1.65%)

UHS Universal Health
$127.94 /

+2.08 (+1.65%)

UHS Universal Health
$127.94 /

+2.08 (+1.65%)

Recommendations
Outfront Media price target raised to $25 from $21 at Citi » 06:25
03/02/21
03/02
06:25
03/02/21
06:25
OUT

Outfront Media

$21.53 /

+1.245 (+6.14%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OUT Outfront Media
$21.53 /

+1.245 (+6.14%)

11/12/20 Citi
Outfront Media price target raised to $21 from $18 at Citi
11/02/20 Morgan Stanley
Lamar Advertising upgraded at Morgan Stanley with recovery not priced in
09/25/20 Citi
Outfront Media upgraded to Buy from Neutral at Citi
06/24/20 Citi
Clear Channel Outdoor upgraded to Buy from Neutral at Citi
OUT Outfront Media
$21.53 /

+1.245 (+6.14%)

  • 23
    Feb
OUT Outfront Media
$21.53 /

+1.245 (+6.14%)

Recommendations
Silk Road Medical price target lowered to $59 from $64 at Citi » 06:25
03/02/21
03/02
06:25
03/02/21
06:25
SILK

Silk Road Medical

$55.35 /

+0.53 (+0.97%)

Citi analyst Joanne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

02/04/21 Piper Sandler
Silk Road recall update 'should be received positively,' says Piper Sandler
01/25/21 Piper Sandler
Silk Road Medical recall primarily manufacturing related, says Piper Sandler
01/13/21 Piper Sandler
Piper Sandler sees no 'larger issue in play' following Silk Road Medical recall
11/11/20 Piper Sandler
Silk Road Medical price target raised to $58 from $54 at Piper Sandler
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

  • 06
    May
SILK Silk Road Medical
$55.35 /

+0.53 (+0.97%)

Recommendations
FibroGen selloff on FDA panel a buying opportunity, says Citi » 06:24
03/02/21
03/02
06:24
03/02/21
06:24
FGEN

FibroGen

$50.35 /

+0.38 (+0.76%)

FibroGen shares are 20%…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

04:47 Today Jefferies
FibroGen downgraded to Hold from Buy at Jefferies
02/01/21 H.C. Wainwright
FibroGen initiated with a Buy at H.C. Wainwright
12/21/20 Mizuho
FibroGen should be bought on PDUFA extension weakness, says Mizuho
10/26/20 Raymond James
FibroGen initiated with an Underperform at Raymond James
FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

FGEN FibroGen
$50.35 /

+0.38 (+0.76%)

Recommendations
Enlivex Therapeutics price target raised to $33 from $22 at H.C. Wainwright » 06:22
03/02/21
03/02
06:22
03/02/21
06:22
ENLV

Enlivex Therapeutics

$14.89 /

-0.3401 (-2.23%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENLV Enlivex Therapeutics
$14.89 /

-0.3401 (-2.23%)

ENLV Enlivex Therapeutics
$14.89 /

-0.3401 (-2.23%)

03/10/20 H.C. Wainwright
Enlivex Therapeutics price target raised to $22 from $20 at H.C. Wainwright
  • 10
    Feb
ENLV Enlivex Therapeutics
$14.89 /

-0.3401 (-2.23%)

ENLV Enlivex Therapeutics
$14.89 /

-0.3401 (-2.23%)

Syndicate
Karuna Therapeutics 2.08M share Secondary priced at $120.00 » 06:21
03/02/21
03/02
06:21
03/02/21
06:21
KRTX

Karuna Therapeutics

$125.01 /

-0.25 (-0.20%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

03/01/21 Oppenheimer
Karuna Therapeutics price target raised to $148 from $135 at Oppenheimer
02/26/21 Mizuho
Karuna Therapeutics price target raised to $150 from $116 at Mizuho
02/26/21 JMP Securities
Karuna Therapeutics price target raised to $167 from $122 at JMP Securities
02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

  • 02
    Mar
KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

Recommendations
Bausch Health price target raised to $37 from $32 at Citi » 06:21
03/02/21
03/02
06:21
03/02/21
06:21
BHC

Bausch Health

$31.76 /

+0.28 (+0.89%)

Citi analyst Navann Ty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHC Bausch Health
$31.76 /

+0.28 (+0.89%)

BHC Bausch Health
$31.76 /

+0.28 (+0.89%)

02/25/21 Barclays
Bausch Health price target raised to $35 from $27 at Barclays
02/17/21 RBC Capital
Bausch Health upgraded to Outperform from Sector Perform at RBC Capital
02/17/21 RBC Capital
Bausch Health upgraded to Outperform from Sector Perform at RBC Capital
02/16/21 JPMorgan
Bausch Health price target raised to $38 from $32 at JPMorgan
BHC Bausch Health
$31.76 /

+0.28 (+0.89%)

BHC Bausch Health
$31.76 /

+0.28 (+0.89%)

BHC Bausch Health
$31.76 /

+0.28 (+0.89%)

Syndicate
Karuna Therapeutics 2.08M share Secondary priced at $120.00 » 06:21
03/02/21
03/02
06:21
03/02/21
06:21
KRTX

Karuna Therapeutics

$125.01 /

-0.25 (-0.20%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

03/01/21 Oppenheimer
Karuna Therapeutics price target raised to $148 from $135 at Oppenheimer
02/26/21 Mizuho
Karuna Therapeutics price target raised to $150 from $116 at Mizuho
02/26/21 JMP Securities
Karuna Therapeutics price target raised to $167 from $122 at JMP Securities
02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

  • 02
    Mar
KRTX Karuna Therapeutics
$125.01 /

-0.25 (-0.20%)

Periodicals
Tesla still relying on supply outside China for Gigafactory 3, DigiTimes reports » 06:20
03/02/21
03/02
06:20
03/02/21
06:20
TSLA

Tesla

$718.14 /

+46.12 (+6.86%)

Tesla originally planned…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$718.14 /

+46.12 (+6.86%)

TSLA Tesla
$718.14 /

+46.12 (+6.86%)

02/25/21 Wedbush
Wedbush sees limited impact to Tesla from chip-driven factory shutdowns
02/22/21 Wedbush
Wedbush estimates Tesla made roughly $1B on bitcoin investment
02/22/21 Argus
Livent upgraded to Buy from Hold at Argus
02/16/21 Wedbush
India factory 'a smart strategic move' by Tesla, says Wedbush
TSLA Tesla
$718.14 /

+46.12 (+6.86%)

TSLA Tesla
$718.14 /

+46.12 (+6.86%)

TSLA Tesla
$718.14 /

+46.12 (+6.86%)

TSLA Tesla
$718.14 /

+46.12 (+6.86%)

Syndicate
Jeld-Wen 8M share Spot Secondary priced at $29.25 » 06:20
03/02/21
03/02
06:20
03/02/21
06:20
JELD

Jeld-Wen

$30.59 /

+0.89 (+3.00%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JELD Jeld-Wen
$30.59 /

+0.89 (+3.00%)

JELD Jeld-Wen
$30.59 /

+0.89 (+3.00%)

02/17/21 B. Riley Securities
Jeld-Wen price target raised to $31 from $25 at B. Riley Securities
02/17/21 Barclays
Jeld-Wen price target lowered to $31 from $32 at Barclays
02/02/21 Northcoast
Jeld-Wen initiated with a Buy at Northcoast
11/04/20 B. Riley Securities
Jeld-Wen price target raised to $25 from $20 at B. Riley Securities
JELD Jeld-Wen
$30.59 /

+0.89 (+3.00%)

  • 02
    Mar
Upgrade
TripAdvisor upgraded to Buy from Neutral at Citi » 06:20
03/02/21
03/02
06:20
03/02/21
06:20
TRIP

TripAdvisor

$49.41 /

-0.365 (-0.73%)

Citi analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$49.41 /

-0.365 (-0.73%)

TRIP TripAdvisor
$49.41 /

-0.365 (-0.73%)

02/23/21 Wells Fargo
TripAdvisor price target raised to $47 from $32 at Wells Fargo
02/22/21 DA Davidson
TripAdvisor price target raised to $46 from $26 at DA Davidson
02/22/21 Stifel
TripAdvisor price target raised to $39 from $26 at Stifel
02/22/21 Credit Suisse
TripAdvisor price target raised to $31 from $25 at Credit Suisse
TRIP TripAdvisor
$49.41 /

-0.365 (-0.73%)

TRIP TripAdvisor
$49.41 /

-0.365 (-0.73%)

TRIP TripAdvisor
$49.41 /

-0.365 (-0.73%)

TRIP TripAdvisor
$49.41 /

-0.365 (-0.73%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.